Skip to main content

Animations

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine

    NEWYORK, NY — The Michael J. Fox Foundation announced a $5.6-million award to drive a Phase 2 clinical trial to investigate the potential of inosine — a naturally occurring chemical that gives rise…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative

    NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research seeks applications from industry and academic researchers for its $10-million 2008 Therapeutics Development Initiative (TDI). The…
    Learn more Save for later

  • Default content image

    New Michael J. Fox Foundation Initiative will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinson's Clinical Trials

    NEWYORK, NY— As part of its ongoing efforts to develop research tools that can speed the availability of life-transforming treatments for Parkinson’s disease, The Michael J. Fox Foundation announced…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation Commits up to $2 Million to Improve Drug Delivery for Parkinson's Disease

    NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research today announced the launch of a new funding program, Improving Delivery of Parkinson’s Disease Therapeutics to the Brain. This $2…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation Commits up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinson's Disease

    NEWYORK, NY — In the interest of accelerating delivery of transformative treatments for Parkinson’s disease, The Michael J. Fox Foundation for Parkinson’s Research today announced the 2008 launch of…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation Awards up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development

    NEWYORK, NY— As part of its ongoing efforts to do whatever it takes to speed delivery of transformative treatments and a cure for Parkinson’s disease, The Michael J. Fox Foundation for Parkinson’s…
    Learn more Save for later

  • Default content image

    The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role Of Lrrk2 and Alpha-Synuclein Genes in Parkinson's Disease

    NEWYORK, NY—The Michael J. Fox Foundation for Parkinson’s Research today announced approximately $2 million in total funding for seven research studies aiming to advance the ability of the Parkinson…
    Learn more Save for later

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.